Submit request or call to make an appointment.
Ependymoma is more common in children than adults, occurring in children most frequently under age 5. Types of ependymoma can be cancerous but typically doesn’t spread, or metastasize, to other areas of the body.
Ependymoma develops in the brain cells that make cerebrospinal fluid. These ependymal cells are found throughout the ventricles and passageways in the brain and spinal cord. When they grow abnormally, they can cause many symptoms depending on where the mass is located.
The five-year survival rate for ependymoma in childhood is about 75%, according to the American Cancer Society. That means 75 out of 100 children with ependymoma survive at least five years. Many go on to live longer and many are cured, meaning no traces of cancer remain.
The neuroscience and oncology specialists with the Norton Children’s Brain & Spinal Tumor Program are working to improve life expectancy for kids with brain tumors. They stay at the forefront of research into new treatments, conduct clinical trials of new drugs and therapies, and publish their findings in prestigious medical journals so others can benefit from their discoveries.
The Brain & Spinal Tumor Program is a collaboration of Norton Children’s Neuroscience Institute and Norton Children’s Cancer Institute, both affiliated with the UofL School of Medicine. Bringing together specialists with different viewpoints, experiences and training means patients benefit from multiple opinions and get customized treatment plans.